Peptide rankings on TikTok: gym culture hype vs. actual evidence

What did @rokkzillaa actually say?

The creator ran through a ranked list of five peptides they claim women use most, covering sexual dysfunction, tanning, joint repair, growth hormone release, and fat loss. The framing was casual and confident, but several of the claims deserve a closer look before anyone pulls out a credit card.

Specifically, they said PT-141 helps with "low libido or menopause," that melanotan gives a "permanent tan," that BPC-157 helps "gut health," that CJC-1295 with ipamorelin is good for "anti-aging sleep" and "protein synthesis," and that tirzepatide, which they called "rezerpatide" and then corrected, helps "burn fat" while people "hold on and retain as much muscle as possible." That last claim is the most loaded and the most worth unpacking.

Does the science back this up?

Some of it does, some of it doesn't, and some of it is so far ahead of the clinical evidence that calling it established is a stretch. Let's go compound by compound.

PT-141 (bremelanotide): This one is actually FDA-approved for hypoactive sexual desire disorder in premenopausal women, under the brand name Vyleesi. So the libido claim has real regulatory backing. However, the creator extends this to menopause without qualification. The approved indication is specifically premenopausal. Palatin Technologies funded the Phase 3 trials published in Obstetrics and Gynecology (2019), and the data do not extend cleanly to menopausal populations.

Melanotan: The creator calls it "the permanent tan peptide." Nothing about melanotan is permanent. More importantly, melanotan II has no FDA approval, has been linked to melanocytic lesion changes, and the European Medicines Agency has warned against its use. Calling it something people "should use" if they hate being pale is irresponsible framing.

BPC-157: The gut health claim has some animal-model support. Sikiric et al. have published extensively on BPC-157's gastroprotective effects in rodents going back to the 1990s and into the 2010s. Human trials are scarce. Joint and tendon claims also rely almost entirely on animal data. This is a compound that shows real promise in preclinical work, but "I myself use BPC-157" is not a clinical endorsement.

CJC-1295 with ipamorelin: These are growth hormone secretagogues. There is legitimate research on GHRH analogs for sleep quality and body composition, but the combination as a compounded product has not been through robust human clinical trials. The FDA has raised concerns about compounded peptides specifically. Calling this good for "protein synthesis" without a citation is vague at best.

Tirzepatide: The creator struggled with the name but landed on the right compound. Tirzepatide (Mounjaro, Zepbound) is FDA-approved for type 2 diabetes and obesity. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed meaningful fat loss. Muscle retention on GLP-1/GIP agonists is an active research question, not a settled fact.

What did they get wrong (or right)?

They got PT-141's mechanism right but oversimplified the indication. Credit where it's due: bremelanotide does work on melanocortin receptors to influence desire, and it is clinically recognized for that purpose in the right population.

They got melanotan badly wrong. Describing it as something you "should use" without mentioning it has no regulatory approval and has documented safety signals is a real problem. The European Medicines Agency flagged it in 2014. Skin changes from melanotan II, including new and changing moles, have been reported in the literature (Dawson et al., 2010, Journal of the European Academy of Dermatology and Venereology). This claim needed a warning, not a sales pitch.

The tirzepatide muscle-retention claim is unverified. Some data from SURMOUNT trials show lean mass loss alongside fat loss, which is the opposite of what was implied. Researchers are actively studying resistance training as a countermeasure. The creator presented this as settled when it is not.

What should you actually know?

Most of these compounds exist in a regulatory gray zone. PT-141 and tirzepatide are FDA-approved drugs, but the others on this list are not approved for the uses described. Melanotan II cannot legally be sold as a drug or supplement in the US or EU. Compounded BPC-157 and CJC-1295/ipamorelin combinations are not the same as approved pharmaceuticals, and the FDA has taken action against compounders marketing unapproved peptides.

The creator mentions "DM me if you have questions" about CJC combinations. That is not a substitute for a licensed prescriber who knows your full health history, current medications, and relevant labs. Any peptide that affects hormone pathways, appetite, skin pigmentation, or tissue repair can have interactions and contraindications that a TikTok comment thread cannot catch.

• Tirzepatide is a prescription drug. It cannot be legally dispensed without a valid prescription from a licensed provider.
• Melanotan II is not FDA-approved and carries documented skin safety concerns.
• BPC-157 and ipamorelin have no FDA-approved human indications as of 2024.
• Anyone considering these compounds should consult a licensed telehealth provider who can review labs and medical history before prescribing.